EphrinB2-EphB4 Signaling in Neurooncological Disease.
Andras PiffkoChristian UhlPeter VajkoczyMarcus CzabankaThomas BrogginiPublished in: International journal of molecular sciences (2022)
EphrinB2-EphB4 signaling is critical during embryogenesis for cardiovascular formation and neuronal guidance. Intriguingly, critical expression patterns have been discovered in cancer pathologies over the last two decades. Multiple connections to tumor migration, growth, angiogenesis, apoptosis, and metastasis have been identified in vitro and in vivo. However, the molecular signaling pathways are manifold and signaling of the EphB4 receptor or the ephrinB2 ligand is cancer type specific. Here we explore the impact of these signaling pathways in neurooncological disease, including glioma, brain metastasis, and spinal bone metastasis. We identify potential downstream pathways that mediate cancer suppression or progression and seek to understand it´s role in antiangiogenic therapy resistance in glioma. Despite the Janus-faced functions of ephrinB2-EphB4 signaling in cancer Eph signaling remains a promising clinical target.
Keyphrases
- papillary thyroid
- squamous cell
- signaling pathway
- poor prognosis
- oxidative stress
- spinal cord injury
- childhood cancer
- cell proliferation
- bone mineral density
- body composition
- risk assessment
- endothelial cells
- vascular endothelial growth factor
- mesenchymal stem cells
- single molecule
- binding protein
- functional connectivity
- blood brain barrier
- postmenopausal women
- cerebral ischemia
- long non coding rna
- human health
- bone regeneration